Three CROs Band Together to Provide All Services -- Three separate Shanghai-based CROs have teamed up in an alliance that will hopes to provide a complete range of services to companies wishing to leverage China's low-cost drug development environment. Global pharmaceutical companies are increasingly outsourcing their R&D to China to reduce their pre-clinical and clinical development costs, which are estimated to be 10% to 20% of that in the U. More details...